I hold tooDream on about a recovery....They got rid of one clown but still pay him as a consultant..The CEO is pathetic...seems more concerned about his bonus and options than anything else
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%